Creating and screening natural product libraries

BAP Wilson, CC Thornburg, CJ Henrich… - Natural product …, 2020 - pubs.rsc.org
Covering: up to 2020 The National Cancer Institute of the United States (NCI) has initiated a
Cancer Moonshot program entitled the NCI Program for Natural Product Discovery. As part …

Sesquiterpenes and their derivatives-natural anticancer compounds: An update

T Abu-Izneid, A Rauf, MA Shariati, AA Khalil… - Pharmacological …, 2020 - Elsevier
Sesquiterpenes belong to the largest group of plant secondary metabolites, which consist of
three isoprene building units. These compounds are widely distributed in various …

SPOP and OTUD7A Control EWS–FLI1 Protein Stability to Govern Ewing Sarcoma Growth

S Su, J Chen, Y Jiang, Y Wang, T Vital… - Advanced …, 2021 - Wiley Online Library
Chromosomal translocation results in development of an Ewing sarcoma breakpoint region
1‐Friend leukemia integration 1 (EWS–FLI1) fusion oncogene in the majority of Ewing …

ETS transcription factors as emerging drug targets in cancer

M Hsing, Y Wang, PS Rennie, ME Cox… - Medicinal research …, 2020 - Wiley Online Library
The ETS family of proteins consists of 28 transcription factors, many of which have been
implicated in development and progression of a variety of cancers. While one family …

Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies

MML Knott, TLB Hölting, S Ohmura, T Kirchner… - Cancer and Metastasis …, 2019 - Springer
While sarcomas account for approximately 1% of malignant tumors of adults, they are
particularly more common in children and adolescents affected by cancer. In contrast to …

Amelioration of Parkinson's disease by pharmacological inhibition and knockdown of redox sensitive TRPC5 channels: Focus on mitochondrial health

B Vaidya, P Gupta, JK Laha, I Roy, SS Sharma - Life Sciences, 2023 - Elsevier
Aims Transient receptor potential canonical 5 (TRPC5) channels are redox-sensitive cation-
permeable channels involved in temperature and mechanical sensation. Increased …

[HTML][HTML] One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma

G Flores, PJ Grohar - Journal of bone oncology, 2021 - Elsevier
EWS/FLI is the defining mutation of Ewing sarcoma. This oncogene drives malignant
transformation and progression and occurs in a genetic background characterized by few …

Fusion genes: A promising tool combating against cancer

X Dai, R Theobard, H Cheng, M Xing… - Biochimica et Biophysica …, 2018 - Elsevier
The driving roles of fusion genes during tumorigenesis have been recognized for decades,
with efficacies demonstrated in clinical diagnosis and targeted therapy. With advances in …

Potential approaches to the treatment of Ewing's sarcoma

H Yu, Y Ge, L Guo, L Huang - Oncotarget, 2016 - pmc.ncbi.nlm.nih.gov
Ewing's sarcoma (ES) is a highly aggressive and metastatic tumor in children and young
adults caused by a chromosomal fusion between the Ewing sarcoma breakpoint region 1 …

Co-targeting JAK1/STAT6/GAS6/TAM signaling improves chemotherapy efficacy in Ewing sarcoma

L Yu, Y Deng, X Wang, C Santos, IJ Davis… - Nature …, 2024 - nature.com
Ewing sarcoma is a pediatric bone and soft tissue tumor treated with chemotherapy,
radiation, and surgery. Despite intensive multimodality therapy,~ 50% patients eventually …